Pr8/22 Cell Line

The cell line Pr8/22 has been derived from P388, a methylcholanthrene-induced lymphoid neoplasm originating in DBA/2 mouse and converted to ascitic form in the first mouse transfer. Pr8/22 is resistant to daunorubicin and is multi drug resistant (MDR). Cells should be treated with the drug at least once a month and before freezing, however after resuscitating daunorubicin should not be added until the first passage. It is advisable to keep a backup culture which is not drug-challenged.

Contributors

Inventor Institute
Timothy Ward Cancer Research UK Manchester Institute
Cat. #: 153248
Tool sub type: Continuous
Unit size: 1×10^6 cells / vial
Research Fields: Cancer;Drug development;Genetics
Organism: Mouse
Tissue: Lymphatic Tissue
Model: Tumour line
Growth properties: Suspension
Cancer Types In Detail: Drug resistant
Alternate name: Pr8/22; PR8/22; P388R
Product description: The cell line Pr8/22 also known as P388 Pr8/22 has been derived from P388 (an immortal murine acute leukaemia cell line). Pr8/22 is resistant to daunorubicin (anthracycline antibiotic) and is multi drug resistant (MDR). Cells should be treated with the drug at least once a month and before freezing, however after resuscitating daunorubicin should not be added until the first passage. It is advisable to keep a backup culture which is not drug-challenged. Pr8/22 proves valuable in studying mechanisms underlying anthracycline antibiotic resistance and for making predictive assessments of resistance patterns. 
Conditional: No
Production details: The cell line Pr8/22 has been derived from P388, a methylcholanthrene-induced lymphoid neoplasm.
Cellosaurus ID: CVCL_4276
Parental cell line: P388
disease: Cancer
Format: Frozen
Shipping conditions: Dry ice
Growth medium: Sub-culture routine: Maintain cultures between 3-9 x 100,000 cells/ml; 5% CO2; 37°C. It is recommended to culture the cells without drug upon resuscitation until the first passage.Culture Medium: RPMI 1640 + 2mM Glutamine + 10% Horse Serum (HS); treat once a month with 0.1µM Daunorubicin.
Subculture routine: Cells should be treated with the drug at least once a month and before freezing, however after resuscitating daunorubicin should not be added until the first passage. It is advisable to keep a backup culture which is not drug-challenged.
References:

McGown et al. 1983. Cancer Chemother Pharmacol. 11(2):113-6. PMID: 6627597.

Comparative studies of the uptake of daunorubicin in sensitive and resistant P388 cell lines by flow cytometry and biochemical extraction procedures.

Related Tools for Cell lines

Cat. # Tool Name
151014 MCF7 AREc32 Cell Line Key Info View Tool
151425 TR146 Cell Line Key Info View Tool
151463 Omega-E Packaging Cell Line Key Info View Tool
151626 A375P beta6-puro Cell Line Key Info View Tool
151630 PDVC57B Cell Line Key Info View Tool

Related News

UM-UC-10 Cell Line. Image courtesy of the European Collection of Authenticated Cell Cultures (ECACC), UK.
Cell Lines

Popular cell lines now available only from CancerTools.org

Read More
Cell Lines

New cell lines: murine melanocyte and melanoblast cell lines from Dr. Elena Sviderskaya

Read More
Image Reference: 2x PTEN -/- mouse prostate cancer cell lines (MuCap system). Histology staining of syngraft tumours (Van Duijn et al., 2018).
Cell Lines

38 new prostate cancer cell lines

Read More

Tool enquiry

Please ensure you use your organisation email address rather than personal where possible, as this helps us locate your organisation in our system faster.

Please note we may take up to three days to respond to your enquiry.

CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.